title: Early deferasirox treatment in a patient with myelodysplastic syndrome results in a long-term reduction in transfusion requirements.
authors.forename: Silvana
authors.initials: S
authors.lastname: Capalbo
authors.forename: Giuseppina
authors.initials: G
authors.lastname: Spinosa
authors.forename: Maria Grazia
authors.initials: MG
authors.lastname: Franzese
authors.forename: Gaetano
authors.initials: G
authors.lastname: Palumbo
mesh_terms: D000368:Aged; D001565:Benzoates / Q000008:administration & dosage*; D001803:Blood Transfusion; D000077588:Deferasirox; D005260:Female; D006454:Hemoglobins / Q000032:analysis*; D006801:Humans; D007502:Iron Chelating Agents / Q000008:administration & dosage*; D019190:Iron Overload / Q000628:therapy; D008297:Male; D009190:Myelodysplastic Syndromes / Q000628:therapy*; D055728:Primary Myelofibrosis / Q000628:therapy; D016896:Treatment Outcome; D014230:Triazoles / Q000008:administration & dosage*
chemical_list: D001565:Benzoates; D006454:Hemoglobins; D007502:Iron Chelating Agents; D014230:Triazoles; D000077588:Deferasirox